Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant crypts.

Authors: Baines, A T; Holubec, H; Basye, J L; Thorne, P; Bhattacharyya, A K; Spallholz, J; Shriver, B; Cui, H; Roe, D; Clark, L C; Earnest, D L; Nelson, M A

Published In Cancer Lett, (2000 Nov 28)

Abstract: We evaluated the effects of dietary selenomethionine supplementation on colonic polyamine levels and the ability of L-selenomethionine supplementation to modulate the carcinogenic activity of azoxymethane (AOM) in the rat colon. Four-week-old male F344 rats were treated with 15 mg/kg body weight of AOM once a week for 2 weeks. Dietary selenomethionine at a concentration of either 1 or 2 ppm was administered in AIN-76A rodent diet to AOM-treated animals for 16 weeks. Aberrant crypt foci (ACF), precursor lesions of colon cancer, were investigated after the 16 week treatment course. Selenomethionine given in the diet at 2 ppm markedly reduced the number of aberrant crypt foci. The multiplicity of ACFs (i.e. the number of aberrant crypts/focus) and the percentage of microadenomas were also affected by selenomethionine in a dose dependent manner. However, evaluation of the colonic tissue polyamine levels between control and treated groups showed no significant difference. These results demonstrate that selenomethionine can modulate the development of AOM-induced premalignant lesions through a polyamine-independent mechanism.

PubMed ID: 11053649 Exiting the NIEHS site

MeSH Terms: Alanine Transaminase; Animals; Anticarcinogenic Agents/pharmacology*; Azoxymethane; Biogenic Polyamines/metabolism*; Body Weight/drug effects; Carcinogens; Colon/drug effects; Colon/metabolism; Colon/pathology; Colonic Neoplasms/chemically induced; Colonic Neoplasms/metabolism; Colonic Neoplasms/prevention & control*; Dietary Supplements; Dose-Response Relationship, Drug; Intestinal Mucosa/drug effects; Intestinal Mucosa/metabolism; Intestinal Mucosa/pathology; Liver/drug effects; Liver/enzymology; Male; Precancerous Conditions/chemically induced; Precancerous Conditions/metabolism; Precancerous Conditions/prevention & control*; Rats; Rats, Inbred F344; Selenium/blood; Selenomethionine/pharmacology*

Back
to Top